Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The nosology of addiction as a medical condition: a concise history and review of contemporary perspectives
    Published on 2025-10-10
    2 months ago
  • Striatal and hippocampal contributions to value-based learning in adolescence
    Published on 2025-10-09
    2 months ago
  • Transdiagnostic prevention in youth mental health, Part II: interventions
    Published on 2025-10-07
    2 months ago
  • Transcription factors Lef1 and Rest stimulate recovery from depressive states
    Published on 2025-10-07
    2 months ago
  • Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M1 and M4 receptors
    Published on 2025-10-04
    2 months ago
  • Early-life neural correlates of behavioral inhibition and anxiety risk
    Published on 2025-10-04
    2 months ago
  • In Memoriam Peter Charles Whybrow, M.D., D.P.M., M.B., F.R.C.P
    Published on 2025-10-04
    2 months ago
« Previous 1 … 3 4 5 6 7 … 143 Next »
Journal of Psychopharmacology
  • Community-based causal evidence that high habitual caffeine consumption alters distinct polysomnography-derived sleep variables
    Published on 2025-10-19
    2 months ago
  • The effects of lithium on cognition in humans: A systematic review
    Published on 2025-10-17
    2 months ago
  • Effects of electroconvulsive shock on astroglial reactivity in a rat model of antipsychotic-induced neurotoxicity
    Published on 2025-10-16
    2 months ago
  • Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs
    Published on 2025-10-16
    2 months ago
  • A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer
    Published on 2025-10-16
    2 months ago
  • β-blockers’ neuropsychiatric risks: Overlooked evidence?
    Published on 2025-10-10
    2 months ago
  • Efficacy and adverse effect profile of vortioxetine in major depressive disorder: A meta-analysis
    Published on 2025-10-08
    2 months ago
« Previous 1 … 3 4 5 6 7 … 134 Next »
European Neuropsychopharmacology
  • Esketamine in bipolar depression: Are we overlooking critical subgroups and dosing details?
    Published on 2025-09-22
    2 months ago
  • Reply to Jianjie Ju and Hui Chen
    Published on 2025-09-22
    2 months ago
  • The potential of applying large-scale multi-omics data to unsupervised learning-based transdiagnostic clusters of individuals with severe mental disorders to identify pharmacodynamic targets
    Published on 2025-09-21
    3 months ago
  • Editorial Board
    Published on 2025-09-17
    3 months ago
  • Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations
    Published on 2025-09-09
    3 months ago
  • Methodological gaps in treatment-resistant depression prediction
    Published on 2025-09-05
    3 months ago
  • Efficacy of pharmacogenetic (PGx)-guided antidepressant treatment on functional outcomes and quality of life in adults with anxiety and affective disorders: A systematic review and meta-analysis
    Published on 2025-09-01
    3 months ago
« Previous 1 … 3 4 5 6 7 … 153 Next »

   Pharma Pub